Skip to main content
SpringerLink
Log in

The Pharmacology of Cocaine

  • Chapter
The Pharmacology of Alcohol and Drugs of Abuse and Addiction

  • 240 Accesses

Abstract

Cocaine has enjoyed a special mystique in the history of medicine, literature, and civilizations. The fathers of modern surgery and psychiatry were proponents of the use of cocaine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burnfeld S (1974). Freud’s studies on cocaine. In Cocaine Papers: Sigmund Freud, Byck R, ed. New York: Stonehill.

    Google Scholar 

  2. Petersen RC (1983). Cocaine: The lessons of history. In Cocaine: A Second Look Rockville, MD: American Council on Marijuana and Other Psychoactive Drugs.

    Google Scholar 

  3. Byck R, ed. (1974). Cocaine Papers: Sigmund Freud. New York: Stonehill

    Google Scholar 

  4. Cohen S (1984). Recent developments in the abuse of cocaine. Bull Narc35:3–14.

    Google Scholar 

  5. National Institute on Drug Abuse (1988). National Household Survey on Drug Abuse. Washington, DC: U.S. Govt. Printing Office.

    Google Scholar 

  6. Kleber HD, Gawin FH (1984). A review of current and experimental treatments. In Cocaine: Pharmacology, Effects and Treatment of Abuse, NIDA Research Monograph, Vol. 50, Grabowski J, ed., pp. 111–129. Washington, DC: U.S. Govt. Printing Office.

    Google Scholar 

  7. Jones R (1985). The pharmacology of cocaine. In Grabowski J, ed., NIDA Res Monogr Ser50:182–192.

    Google Scholar 

  8. Smith DE (1986). Cocaine-alcohol abuse: Epidemiological, diagnostic and treatment considerations. JPsychoact Drugs18 (2): 117–129

    CAS  Google Scholar 

  9. Gold MS (1987). Crack abuse: Its implications and outcomes. Resid Staff Physician33:45–53.

    Google Scholar 

  10. Gold MS, Washton AM, Dackis CA (1985). Cocaine abuse: Neurochemistry, phenomenology and treatment. In Adams EH, Kozel NJ, eds., NIDA Res Monogr Ser61:130–150.

    Google Scholar 

  11. Gold MS (1987). The cocaine epidemic: What are the problems, insights and treatments? Pharmacy Times, 53:36–42.

    Google Scholar 

  12. Perez-Reyes, Diguiseppi BS, Ondrusek G, et al. (1982). Freebase cocaine smoking. Clin Pharmacol Ther32:459.

    Article  Google Scholar 

  13. Siegel RK (1982). Cocaine smoking. JPsychoact Drugs14:271.

    CAS  Google Scholar 

  14. Siegel RK (1985). New patterns of cocaine use: Changing doses and routes. NIDA Res Monogr Ser61:204–220.

    CAS  Google Scholar 

  15. Van Dyke C, Ungerer J, Jatlow P, et al. (1982). Intranasal cocaine dose relationships of psychological effects and plasma levels. Int J Psychiatry Med12:1–13.

    Article  PubMed  Google Scholar 

  16. Washton AM, Gold MD, Pottash ALC (1983). Intranasal cocaine addiction. Lancet2:1374.

    Article  PubMed  CAS  Google Scholar 

  17. Bose KC (1976). Cocaine intoxication and its demoralizing effects. Br Med J1902; 1:1020–1022. In Cocaine-Summaries of Psychosocial Research, pp. 66–67. Rockville, MD: National Institute of Drug Abuse (NIDA).

    Google Scholar 

  18. Fischman MW, Schuster CR, Resnekov L, et al. (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry33:983–989.

    PubMed  CAS  Google Scholar 

  19. Muscholl E (1961). Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br J Pharmacol16:352–359.

    CAS  Google Scholar 

  20. Taylor D, Ho BT (1977). Neurochemical effects of cocaine following acute and repeated injection. JNeurosci Res3:95–101.

    Article  CAS  Google Scholar 

  21. Gay GR (1982). Clinical management of acute and chronic cocaine poisoning. Ann Emerg Med11:562–572.

    Article  PubMed  CAS  Google Scholar 

  22. Kilbey MM, Ellinwood EH (1977). Chronic administration of stimulant drugs: Response modification. In Cocaine and Other Stimulants, Ellinwood H, Kilbey M, eds., pp. 410–429. New York: Plenum Press.

    Google Scholar 

  23. Millman RB (1986). Drug dependence: General principles of diagnosis and treatment. In Psychiatry Update, Vol. 5, pp. 122–136. Washington, DC: American Psychiatry Press.

    Google Scholar 

  24. Brower KJ, Paredes A (1987). Cocaine withdrawal (letter). Arch Gen Psychiatry44:298–299.

    Google Scholar 

  25. Kleber HD, Gawin FH (1987). Cocaine withdrawal (reply). Arch Gen Psychiatry44:298–299.

    Google Scholar 

  26. Miller NS, Dackis CA, Gold MS (1987). The relationship of addiction, tolerance and dependence: A neurochemical approach. JSubst Abuse Treat4:197–207.

    Article  CAS  Google Scholar 

  27. Lasagna L, Von Felsinger JM, Beecher HK (1955). Drug-induced mood changes in man: I. Observations on healthy subjects, chronically ill patients, and post–addicts. JAMA157:1066–1120.

    Google Scholar 

  28. Gawin FH, Kleber HD (1986). Abstinence symptomatology and psychiatric diagnosis in chronic cocaine abusers. Arch Gen Psychiatry43:107–113.

    PubMed  CAS  Google Scholar 

  29. Gold MS, Pottash ALC, Annitto WJ, et al. (1983). Cocaine withdrawal: Efficacy of tyrosine. Soc Neurosci Abstr9:157.

    Google Scholar 

  30. Gold MS, Dackis CA (1984). New insights and treatments: Opiate withdrawal and cocaine addiction. Clin Therl(\)\6–2\

    Google Scholar 

  31. Keller MB, Shapiro RW, Lavori PW, et al. (1982). Recovery in major depressive disorder: Analysis with the life table and regression models. Arch Gen Psychiatry39:905–910.

    PubMed  CAS  Google Scholar 

  32. Dackis CA, Gold MS (1985). New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev9:469–477.

    Article  PubMed  CAS  Google Scholar 

  33. Edwards G, Arrif A, Hodgson R (1981). Nomenclature and classification of drug and alcohol related problems. Bull WHO59:225–242.

    PubMed  CAS  Google Scholar 

  34. American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3d Ed. Washington, DC: American Psychiatric Association.

    Google Scholar 

  35. Kuehnle J, Spitzer R (1981). DSM–III classification of substance use disorders. In Substance Abuse: Clinical Problems and Perspectives, Lowinson JH, ed., pp. 19–23. Baltimore: Williams & Wilkins.

    Google Scholar 

  36. Fischman MW, Schuster CR (1982). Cocaine self-administration in humans. Fed Proc41:241–246.

    PubMed  CAS  Google Scholar 

  37. Runsaville BJ, Spitzer RL, Williams JBW (1986). Proposed changes in DSM-III substance use disorders: Description and rationale. Am J Psychiatry143:468.

    Google Scholar 

  38. Gawin FH, Kleber HD (1986). Abstinence symptomatology and psychiatry diagnosis in cocaine abusers: Clinical observations. Arch Gen Psychiatry43:107–113.

    PubMed  CAS  Google Scholar 

  39. Keller MB, Shapiro RW (1982). “Double depression”: Superimposition of acute depressive disorders. Am J Psychiatry 139:438–442.

    Google Scholar 

  40. Gold MS (1984). 800–COCAINE. New York: Bantam.

    Google Scholar 

  41. Jellinek EM (1960). The disease concept of alcoholism. New Haven, CT: Hillhouse Press.

    Google Scholar 

  42. Verebey K, Gold MS (1984). The psychopharmacology of cocaine. Psychiatr Ann14 (10): 714–723.

    Google Scholar 

  43. Goodman L, Gilman AG, eds. (1980). The Pharmacological Bases of Therapeutics, 6th Ed. New York: Macmillan.

    Google Scholar 

  44. Spiehler VR, Reed D (1985). Brain concentrations of cocaine and benzoylec-gonine in fatal cases. J Forensic Sci30:1003–1011.

    PubMed  CAS  Google Scholar 

  45. Van Dyke C, Jatlow P, Barash PG, et al. (1978). Oral cocaine: Plasma concentrations and central effects. Science100:211–213.

    Article  Google Scholar 

  46. Lesse H (1980). Prolonged effects of cocaine on hippocampal activity. Commun Psychopharmacol4:247.

    PubMed  CAS  Google Scholar 

  47. Misra AL, Nayak PK, Block R, et al. (1975). Estimation and disposition of [3H]benzoylecgnonine and pharmacological activity of some cocaine metabolites. J Pharm Pharmacol27:784–786.

    Article  PubMed  CAS  Google Scholar 

  48. Borne RG, Bedford JA, Buelke JL, et al. (1977). Biological effects of cocaine derivatives: I. Improved synthesis and pharmacological evaluation of norocaine J Pharm Sci66:119–120.G

    Article  PubMed  CAS  Google Scholar 

  49. Wilkinson P, Van Dyke C, Jatlow P, et al. (1980). Intranasal and oral cocaine kinetics. Clin Pharmacol Ther27:386–394.

    Article  PubMed  CAS  Google Scholar 

  50. Kilbey MM, Ellinwood EH, Easier ME (1979). Effect of chronic cocaine pretreatment in kindled seizures and behavioral stereotypes. Exp Neurol64:306–314.

    Article  PubMed  CAS  Google Scholar 

  51. Post RM, Kopanda RT, Lee A (1975). Progressive behavioral changes during chronic lidocaine administration: Relationship to kindling. Life Sci17:943.

    Article  PubMed  CAS  Google Scholar 

  52. Striplig JS, Grämlich CA, Cunningham MG (1983). Effect of cocaine and lidocaine on the development of kindled seizures. Soc Neurosci Abstr9:486.

    Google Scholar 

  53. Wise RA (1984). Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr Ser50:15–33.

    CAS  Google Scholar 

  54. Taylor DL, Beng TH, Fagan JD (1979). Increased dopamine receptor binding in rat brain by repeated cocaine injections. Commun Psychopharmacol3:137–142.

    PubMed  CAS  Google Scholar 

  55. Ross SB, Renyi AL (1967). Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharma2:181–186.

    Article  PubMed  CAS  Google Scholar 

  56. Cooper JR, Bloom FE, Roth RH (1982). The Biochemical Basis of Neuropharmacology. New York: Oxford University Press.

    Google Scholar 

  57. Langer SZ, Enero MA (1974). The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: Its relationship to the metabolic fate of released norepinephrine. J Pharmacol Ther191:431–443.

    CAS  Google Scholar 

  58. Whitby LG, Hertting G, Axelrod J (1960). Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature187:604–605.

    Article  PubMed  CAS  Google Scholar 

  59. Roberts DC, Corcoran ME, Fibiger HC (1977). On the role of ascending cate-cholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav6:615–620.

    Article  PubMed  CAS  Google Scholar 

  60. Banerjee SP, Sharma VK, Kung-Cheung LS, et al. (1979). Cocaine and D-amphetamine-induced changes in central beta-adrenoceptor sensitivity: Effects of acute and chronic drug treatment. Brain Res175:119–130.

    Article  PubMed  CAS  Google Scholar 

  61. Ross SB, Renyi AL (1969). Inhibition of the uptake of 5-hydroxytryptamine in brain tissue. Eur J Pharmacol7:270–277.

    Article  PubMed  CAS  Google Scholar 

  62. Freidman E, Gershon S, Rotrosen J (1975). Effects of acute cocaine treatment on the turnover of 5-hydroxy try ptamine in the rat brain. Br J Pharmacol54:61–64.

    Google Scholar 

  63. Knapp S, Mandell A J (1972). Narcotic drugs: Effects on the serotonin biosyn-thetic systems of the brain. Science177:1209–1211.

    Article  PubMed  CAS  Google Scholar 

  64. Pradhan SN, Battachargya AK, Pradhan S (1978). Serotonergic manipulation of the behavioral effects of cocaine in rats. Common Psychopharmacol2:481–486.

    CAS  Google Scholar 

  65. Schubert J, Fryo B, Nyback H, Sedvall G (1970). Effects of cocaine and amphetamine on the metabolism of tryptophan and 5-hydroxy try ptamine in mouse brain in vivo. J Pharm Pharmacol22:860–862.

    Article  PubMed  CAS  Google Scholar 

  66. National Commission on Marijuana and Drug Abuse (1973). Drug use in America: Problems in perspective. In Second Report of the National Commission on Marijuana and Drug Abuse Washington, DC: National Institute of Abuse.

    Google Scholar 

  67. Adams EH, Kozel NJ, eds. (1985). Cocaine use in America: Introduction and overview. NIDA Res Monogr Ser 61:45–49.

    Google Scholar 

  68. Miller NS, Gold MS, Klahr AL, et al. (1988). Alcohol use in cocaine addicts. Subst Abuse %4)\2\6–22\

    Google Scholar 

  69. Miller NS, Gold MS, Klahr AL, et al. (1990). Cannabis diagnosis of patients receiving treatment for cocaine dependence./Subst Abuse 2: 107–111.

    CAS  Google Scholar 

  70. Grinspoon L, Bakalar JB (1985). Cocaine: A Drug and Its Social Evolution. New York: Basic Books.

    Google Scholar 

  71. Freedman AM, Kaplan HI, Saddock BJ (1975). Comprehensive Textbook of Psychiatry, 2nd Ed., Vol. 2, Baltimore, MD: Williams and Wilkins.

    Google Scholar 

  72. Van Dyck C, Byck R (1982). Cocaine. Sci Am246:128–141.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cornell University Medical College, New York Hospital-Cornell Medical Center, 21 Bloomingdale Road, 10605, New York, USA

    Norman S. Miller M.D.

Authors
  1. Norman S. Miller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York

About this chapter

Cite this chapter

Miller, N.S. (1991). The Pharmacology of Cocaine. In: The Pharmacology of Alcohol and Drugs of Abuse and Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3044-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3044-1_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7774-3

  • Online ISBN: 978-1-4612-3044-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation